ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a $15.5-million investment to enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results